We have studied the effect of sub-minimal inhibitory concentrations (sub-MIC) of ciprofloxacin and fleroxacin on capsulated (K+) and non-capsulated (K-) Gram-negative bacilli (Escherichia coli O1:K1, O7:K1, O1:K-, O7:K-, and Klebsiella oxytoca) as well as on Staphylococcus aureus and we investigated the interaction of antibiotic pretreated bacteria with human serum and polymorphonuclear leukocytes (PMN). Following overnight growth in the presence of 1/2 MIC of the antibiotics, bacteria were opsonized in human serum and incubated with PMN. Opsonophagocytosis was quantified as the ratio of uptake by PMN of radioactively labeled bacteria. Ciprofloxacin and fleroxacin enhanced the phagocytosis rate of E. coli K+ strains (control 5-10%; 1/2 MIC of ciprofloxacin and fleroxacin 70-80%) of K. oxytoca (control O-2%; 1/2 MIC of ciprofloxacin and fleroxacin 35-40%) as well as of Staph. aureus (control 5-10%; 1/2 MIC of the antibiotics 35-40%). Opsonophagocytosis of K- strains was not altered. The enhancement of opsonophagocytosis was a complement dependent process. Exposure of capsulated E. coli to ciprofloxacin as well as to fleroxacin resulted in decreased amounts of the capsular antigen.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0934-8840(11)80090-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A new molecularly imprinted nanocatalytic probe for RRS determination of trace enrofloxacin based on covalent organic framework polymer.
J Colloid Interface Sci
March 2025
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China; Guangxi Key Laboratory of Environmental Pollution Control Theory and Technology, Guilin 541004, China; Guangxi Key Laboratory of Environmental Processes and Remediation in Ecologically Fragile Regions, Guilin 541004, China. Electronic address:
A new nanopalladium surface molecularly imprinted covalent organic framework (MICOF) catalytic probe (Pd@TpPa) for enrofloxacin (ENR) was synthesized by molecular imprinting technology, using 1,3,5-triformylphloroglucinol (Tp) and p-phenylenediamine (Pa) as monomers, ENR as the template molecule, and palladium nanoparticles (PdNP) as the core of nanocatalytic probe. This nanoprobe not only specifically recognizes ENR but also catalyzes the cupric tartrate-glucose (GL) indicator reaction. The amino groups in TpPa replace the tartrate ions, forming a new complex with Cu.
View Article and Find Full Text PDFAuthors' reply to comments on "Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt".
Eur J Pharm Biopharm
November 2024
College of Pharmacy, Jiamusi University, Heilongjiang Province, Jiamusi 154007, China.
This article responds to Dr. Shayanfar's comment "Improvement of photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesizing fleroxacin-D-tartaric acid pharmaceutical salt". We rationalized and explained the solubility study portion of the published novel pharmaceutical salt (fleroxacin-D-tartaric acid, FL-D-TT).
View Article and Find Full Text PDFImproved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt.
Eur J Pharm Biopharm
October 2024
College of Pharmacy, Jiamusi University, Heilongjiang Province, Jiamusi 154007, China.
Article Synopsis
- Researchers synthesized a new salt called Fleroxacin-D-tartaric acid dihydrate (FL-D-TT) to enhance the solubility of the fluoroquinolone antibiotic fleroxacin (FL), using D/L-tartaric acid.
- Structural analyses confirmed that D-tartaric acid interacts more effectively with FL, leading to a significant increase in solubility in water (up to 9.71 mg/mL) compared to FL alone (0.39 mg/mL).
- The new compound also showed improved antimicrobial activity, hygroscopic stability, and photostability, making FL-D-TT a promising alternative for enhancing the efficacy of fleroxacin.
Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1.
J Biol Chem
August 2024
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado, Aurora, Colorado, USA. Electronic address:
Drug metabolism is one of the main processes governing the pharmacokinetics and toxicity of drugs via their chemical biotransformation and elimination. In humans, the liver, enriched with cytochrome P450 (CYP) enzymes, plays a major metabolic and detoxification role. The gut microbiome and its complex community of microorganisms can also contribute to some extent to drug metabolism.
View Article and Find Full Text PDFIdentification and drug resistance of pathogen of ulcerative skin disease and its immune responses and protective efficacy after vaccination in a giant spiny frog, Quasipaa spinosa.
Microb Pathog
February 2024
Institute of Hydrobiology, Zhejiang Academy of Agricultural Sciences, Hangzhou, 310000, China. Electronic address:
Objective: In order to explore the pathogen of the ulcerative skin disease in giant spiny frog (Quasipaa spinosa), and to provide theoretical basis for the prevention and control of the disease in practical production, this study was carried out to isolate and identify the pathogenic bacteria from the sick frogs suffering from rotting skin disease and to carry out the immunization test of the inactivated vaccine.
Methods: Physiological and biochemical characterization, and molecular biology of the pathogenic bacteria were identified, and drug screening and immunization responses were also carried out.
Results: The dominant bacterium QS01 was isolated from the lesions of diseased giant spiny frogs, which was confirmed to be the causative agent of the rotting skin disease of giant spiny frogs by artificial regression infection test.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!